Executive Team

Michael Feldschuh, CEO and President
Michael Feldschuh earned his bachelors degree in Pre-Med studies at Columbia College, Columbia University in 1991.  Prior to joining Daxor’s executive team in December of 2014 he served as a member of the board of directors for one and a half years prior.   Michael headed his own hedge fund, Aristarc Capital, from 2009 to 2013 specializing in quantitative strategies. Prior to founding his own fund, Michael was a Managing Director at Morgan Stanley from 2005 to 2009 and also served as a Managing Director and Portfolio Manager at Millennium Partners in New York from 1997-2005. Michael was a proprietary trader for Morgan Stanley & Co. from 1994-1997. Michael began his career at D.E. Shaw & Co. in New York, where he worked with Jeffery Bezos prior to Bezos’s founding of Amazon.
Eric P. Coleman, Chief Financial Officer
Mr. Coleman joined Daxor Corporation as CFO in June 2016. He is a licensed CPA and has more than 25 years of finance leadership experience, including tenures with high-profile international public companies in the technology, manufacturing, and medical device industries. Mr. Coleman received his Bachelors Degree in Accounting from Xavier University. Mr. Coleman is responsible for overseeing the financial activities of Daxor as well as leading the ongoing business development of the company with potential JV partners to enhance shareholder value in a transformative way. He received his Bachelors Degree in Accounting from Xavier University.
Diane Meegan, Corporate Secretary

Diane Meegan joined DAXOR Corporation in February 2002 as the Senior Executive Assistant to the CEO and President. Ms. Meegan is currently the Corporate Secretary. Ms. Meegan served as the Official Executive Assistant to the CEO of Newbridge Securities, a wholly owned subsidiary of Citigroup, for 13 years. For 4 years, she served as a member of their Problem Review Board. In the past 2 years, she served as the Executive Assistant to the Head of Operations at Instinet Clearing Services.

Gary Fischman, Ph.D., Vice President, R&D
Gary Fischman obtained his Doctor of Podiatric Medicine from the Pennsylvania College of Podiatric Medicine and his Ph.D. in Pathology from Thomas Jefferson University. He joined DAXOR in May 1998 and he comes from a background of teaching and research. He is a diplomate of the American Academy of Pain Management.